Clinical Trials

RECRUITING
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Effectiveness of CABA-201 in Subjects With Active Lupus
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Effectiveness of CABA-201 in Subjects With Active Lupus
Conditions:
Systemic Lupus Erythematosus Lupus Nephritis
Locations:
📍 Orange, California, United States
📍 Sacramento, California, United States
📍 Atlanta, Georgia, United States
📍 Kansas City, Kansas, United States
9 more locations available...
RECRUITING
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
This phase Ib trial studies the side effects of nivolumab and to see how well it works in treating patients with autoimmune disorders and cancer that ...
Conditions:
Autoimmune Disease Crohn Disease Dermatomyositis Hematopoietic and Lymphoid Cell Neoplasm
10 more conditions available...
Locations:
📍 Birmingham, Alabama, United States
📍 Palo Alto, California, United States
📍 Sacramento, California, United States
📍 New Haven, Connecticut, United States
47 more locations available...
NOT_YET_RECRUITING
REACT-01: Reversing Autoimmunity Through Cell Therapy
This is a phase 1, open-label, non-randomized study enrolling pediatric and young adult research patients with treatment-refractory Lupus (SLE), to ex...
Conditions:
Systemic Lupus Erythematosus
Locations:
📍 Seattle, Washington, United States
RECRUITING
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Patients With Active Lupus (SLE)
The purpose of this study is to assess the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Lupus (SL...
Conditions:
Systemic Lupus Erythematosus
Locations:
📍 Birmingham, Alabama, United States
📍 Tucson, Arizona, United States
📍 Fontana, California, United States
📍 Hemet, California, United States
192 more locations available...
RECRUITING
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Background: Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males. People with SLE are often treated ...
Conditions:
Systemic Lupus Erythematosus (Sle) Primary Ovarian Insufficiency (Poi)
Locations:
📍 Bethesda, Maryland, United States

Total Trials: 106 - 110 of 110